The agreement stipulates that $1.6 billion will be provided to states to use for opioid abatement, with approximately $14.7 million of those funds awarded to California. Additional bankruptcies from other opioid manufacturers, including with Endo Pharmaceuticals and Purdue Pharmaceuticals L.P., are still pending.